Vaziva SAS Enters Biotech Scene with Successful IPO on NYSE Euronext Paris
Vaziva SAS, a French biotech company, has made a significant entrance into the European biotech arena with its recent IPO on the NYSE Euronext Paris, positioning itself for growth and innovation in the sector.
2 minutes to read